跳至主要内容
临床试验/NCT04766138
NCT04766138已完成不适用

Neurophysiological Mechanism in Sacral Neuromodulation in Patients Suffering From Fecal Incontinence

The California Medical Innovations Institute, Inc.2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Duration-based device expulsion parameters

研究概览

简要总结

Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as much as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal.

The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. It exceeds previous attempts to make artificial stool for evaluation of defecation and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of healthy subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction. It is anticipated that Fecobionics will shed light on the neurophysiology of defecation in health and disease, including understanding the effect of biofeedback and neuromodulatory effect of SNS. It will be of great value to provide endpoints in normal subjects that in future studies can be objective measures for monitoring treatment efficacy. The present protocol is on normal subjects only.

详细描述

Fecal continence is maintained by several mechanisms including anatomical factors, anorectal sensation, rectal compliance, stool consistency, anal muscle strength, mobility, and psychological factors. The homeostatic balance is easily disturbed by functional or structural anorectal disturbances that may coexist. Common anorectal disorders are fecal incontinence, functional anorectal pain, and functional defecation disorders. These conditions greatly affect life quality for the patients. Current technologies for anorectal functional assessment studies have limitations and often overlap is found between patient groups with lack of correlation between measurements and symptoms. Defecation physiology has been studied for many years but the mechanics and mechanosensation of defecation are still not well understood.

Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development of Fecobionics was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as close as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal as well as other parameters

The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. Fecobionics exceeds previous attempts to make artificial stool for evaluation of defecation and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of healthy subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction. It is anticipated that Fecobionics will shed light on the neurophysiology of defecation in health and disease, including understanding the effect of biofeedback and neuromodulatory effect of SNS. It will be of great value to provide endpoints in normal subjects that in future studies can be objective measures for monitoring treatment efficacy. The present protocol is on normal subjects only, i.e. studying mechanisms of defecation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must provide written informed consent;
  • Age 18 years and of age of legal consent;
  • Normal defecation pattern;
  • Within normal range for fecal incontinence severity index (FISI) and Wexner Constipation Scoring System (CSS) scores.

排除标准

  • Female, who is pregnant or lactating;
  • Prior abdominal surgery;
  • Diagnosis of fecal incontinence, constipation or anorectal pain.
  • For Patients with Fecal Incontinence (in University of California, San Diego):
  • Inclusion Criteria:
  • Subject must provide written informed consent;
  • Age 18 years and of age of legal consent;
  • Diagnosed Fecal Incontinence and scheduled for sacral neuromodulation treatment
  • Exclusion Criteria:
  • Female, who is pregnant or lactating;
  • Prior abdominal surgery

结局指标

主要结局

Duration-based device expulsion parameters

时间窗: 1 year

Expulsion Duration - The time it takes to defecate Fecobionics

Pressure-based device expulsion parameters

时间窗: 1 year

Pressure difference between front and rear of Fecobionics device - A measure of anal sphincter relaxation and key to the determination of defecation phases. Pressure profiles

次要结局

  • Device orientation and bending-based expulsion parameters(1 year)
  • Shape-based expulsion parameters(1 year)
  • Mechanical-based expulsion parameters Endpoints(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hans Gregersen, PhD

Research Professor

The California Medical Innovations Institute, Inc.

研究点 (2)

Loading locations...

相似试验

Trial to Evaluate Fecobionics in Healthy Subjects... | 临床试验